Literature DB >> 11865669

Structural insights into the promiscuity and function of the human pregnane X receptor.

Ryan E Watkins1, Schroeder M Noble, Matthew R Redinbo.   

Abstract

The pregnane X receptor (PXR) is a promiscuous nuclear receptor that responds to a wide variety of drugs, xenobiotics and endogenous compounds, and plays a critical role in mediating drug-drug interactions in humans. PXR is the master regulator of the expression of the CYP3A4 gene, which encodes for the most abundant and promiscuous drug-metabolizing enzyme in humans. PXR also regulates the expression of other genes involved in xenobiotic metabolism, including CYP2C8, CYP2C9, CYP2B6, GSTA2 and MDR1, as well as genes critical to bile acid metabolism. While PXR functions as a xenobiotic sensor in numerous vertebrates, its relatively low sequence conservation across species causes the PXRs from different organisms to respond to distinct subsets of xenobiotics. Thus, PXR promiscuity is directed and not random. The recent determination of crystal structures of the ligand binding domain of human PXR has provided the first detailed molecular view of this promiscuous receptor, and has advanced our understanding of its varied biological functions. We review the evidence establishing the binding promiscuity of PXR and its directed specificity in different species, and analyze the structural determinants of these characteristics. In addition, we examine the relationship between the interaction of PXR with ligands and the manner in which CYP3A4 is thought to bind to substrate molecules. The accumulating structural and functional data on PXR may facilitate the development of improved methods for in vitro, in vivo and in silico screening for PXR activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865669

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  32 in total

Review 1.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

4.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.

Authors:  Matthew D Krasowski; Kazuto Yasuda; Lee R Hagey; Erin G Schuetz
Journal:  Mol Endocrinol       Date:  2005-02-17

5.  Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.

Authors:  Snehal Dabir; Amy Kluge; Mohammad A Aziz; Janet A Houghton; Afshin Dowlati
Journal:  Cancer Biol Ther       Date:  2011-07-15       Impact factor: 4.742

Review 6.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

7.  In silico investigation of agonist activity of a structurally diverse set of drugs to hPXR using HM-BSM and HM-PNN.

Authors:  Yi-Ming Zhang; Mei-Jia Chang; Xu-Shu Yang; Xiao Han
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

8.  Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.

Authors:  Aditya Garg; Angela Zhao; Sarah L Erickson; Subhajit Mukherjee; Aik Jiang Lau; Laurie Alston; Thomas K H Chang; Sridhar Mani; Simon A Hirota
Journal:  J Pharmacol Exp Ther       Date:  2016-07-20       Impact factor: 4.030

Review 9.  CAR and PXR: the xenobiotic-sensing receptors.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  Steroids       Date:  2006-12-20       Impact factor: 2.668

10.  Structural basis of human pregnane X receptor activation by the hops constituent colupulone.

Authors:  Denise G Teotico; Jason J Bischof; Li Peng; Steven A Kliewer; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.